APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs for Vancomycin-Resistant Enterococcus Faecium

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchDrugs for Vancomycin-Resistant Enterococcus Faecium Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs for Vancomycin-Resistant Enterococcus Faecium Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs for Vancomycin-Resistant Enterococcus Faecium Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

According to APO Research, the global Drugs for Vancomycin-Resistant Enterococcus Faecium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs for Vancomycin-Resistant Enterococcus Faecium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs for Vancomycin-Resistant Enterococcus Faecium is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Vancomycin-Resistant Enterococcus Faecium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Drugs for Vancomycin-Resistant Enterococcus Faecium market include Microbiotix, MGB Biopharma Limited, Lytix Biopharma, LegoChem Biosciences, Helix BioMedix, Enanta Pharmaceuticals, Cellceutix Corporation, Aphios Corporation and Alvogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs for Vancomycin-Resistant Enterococcus Faecium market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs for Vancomycin-Resistant Enterococcus Faecium market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Vancomycin-Resistant Enterococcus Faecium market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Vancomycin-Resistant Enterococcus Faecium.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Drugs for Vancomycin-Resistant Enterococcus Faecium market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Company

Microbiotix

MGB Biopharma Limited

Lytix Biopharma

LegoChem Biosciences

Helix BioMedix

Enanta Pharmaceuticals

Cellceutix Corporation

Aphios Corporation

Alvogen

Alchemia Limited

Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Type

Ampicillin

Daptomycin

Quinupristin/dalfopristin

Linezolid

Chloramphenicol

Others

Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Application

Hospital

Clinic

Others

Drugs for Vancomycin-Resistant Enterococcus Faecium Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Vancomycin-Resistant Enterococcus Faecium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Vancomycin-Resistant Enterococcus Faecium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Vancomycin-Resistant Enterococcus Faecium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Region (2021-2026) Table 4. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Region (2027-2032) Table 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Type (2021-2026) Table 9. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share Forecasted by Type (2027-2032) Table 11. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2021-2026) Table 24. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share Forecasted by Application (2027-2032) Table 26. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Trends Table 37. Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Drivers Table 38. Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Opportunities and Challenges Table 39. Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Restraints Table 40. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Market Share by Company (2021-2026) Table 42. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Key Company Headquarters & Area Served Table 44. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Company, Product Type & Application Table 45. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Drugs for Vancomycin-Resistant Enterococcus Faecium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Microbiotix Company Information Table 49. Microbiotix Business Overview Table 50. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 52. Microbiotix Recent Development Table 53. MGB Biopharma Limited Company Information Table 54. MGB Biopharma Limited Business Overview Table 55. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 57. MGB Biopharma Limited Recent Development Table 58. Lytix Biopharma Company Information Table 59. Lytix Biopharma Business Overview Table 60. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 62. Lytix Biopharma Recent Development Table 63. LegoChem Biosciences Company Information Table 64. LegoChem Biosciences Business Overview Table 65. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 67. LegoChem Biosciences Recent Development Table 68. Helix BioMedix Company Information Table 69. Helix BioMedix Business Overview Table 70. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 72. Helix BioMedix Recent Development Table 73. Enanta Pharmaceuticals Company Information Table 74. Enanta Pharmaceuticals Business Overview Table 75. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 77. Enanta Pharmaceuticals Recent Development Table 78. Cellceutix Corporation Company Information Table 79. Cellceutix Corporation Business Overview Table 80. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 82. Cellceutix Corporation Recent Development Table 83. Aphios Corporation Company Information Table 84. Aphios Corporation Business Overview Table 85. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 87. Aphios Corporation Recent Development Table 88. Alvogen Company Information Table 89. Alvogen Business Overview Table 90. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 92. Alvogen Recent Development Table 93. Alchemia Limited Company Information Table 94. Alchemia Limited Business Overview Table 95. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio Table 97. Alchemia Limited Recent Development Table 98. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2026) Table 101. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Country (2027-2032) Table 103. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2026) Table 106. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2026) Table 111. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Country (2027-2032) Table 113. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2026) Table 116. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2026) Table 121. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Drugs for Vancomycin-Resistant Enterococcus Faecium Product Image Figure 3. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2021-2032) & (US$ Million) Figure 5. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Region: 2025 VS 2032 Figure 6. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Region (2021-2032) Figure 7. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Ampicillin Image Figure 13. Global Ampicillin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Daptomycin Image Figure 15. Global Daptomycin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Quinupristin/dalfopristin Image Figure 17. Global Quinupristin/dalfopristin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Linezolid Image Figure 19. Global Linezolid Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Chloramphenicol Image Figure 21. Global Chloramphenicol Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Type 2025 VS 2032 Figure 26. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Type (2021-2032) Figure 27. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Type (2021-2032) Figure 29. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Type (2021-2032) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Clinic Image Figure 34. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Application 2025 VS 2032 Figure 39. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2021-2032) Figure 40. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2021-2032) Figure 42. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Drugs for Vancomycin-Resistant Enterococcus Faecium Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2032) Figure 49. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2032) Figure 52. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2032) Figure 55. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2032) Figure 58. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Ampicillin
  • Daptomycin
  • Quinupristin/dalfopristin
  • Linezolid
  • Chloramphenicol
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Microbiotix
  • MGB Biopharma Limited
  • Lytix Biopharma
  • LegoChem Biosciences
  • Helix BioMedix
  • Enanta Pharmaceuticals
  • Cellceutix Corporation
  • Aphios Corporation
  • Alvogen
  • Alchemia Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2021-2032)
  5. 1.4.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2021-2026)
  6. 1.4.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Region (2027-2032)
  7. 1.5 Key Regions Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size (2021-2032)
  8. 1.5.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (2021-2032)
2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Ampicillin
  3. 2.1.2 Daptomycin
  4. 2.1.3 Quinupristin/dalfopristin
  5. 2.1.4 Linezolid
  6. 2.1.5 Chloramphenicol
  7. 2.1.6 Others
  8. 2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Type
  9. 2.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions
  13. 2.3.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Type (2021-2026)
3 Drugs for Vancomycin-Resistant Enterococcus Faecium Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Application
  6. 3.2.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Regions
  10. 3.3.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Trends
  2. 4.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Drivers
  3. 4.3 Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Opportunities and Challenges
  4. 4.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue (2021-2026)
  2. 5.2 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Key Company Headquarters & Area Served
  4. 5.4 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Company, Product Type & Application
  5. 5.5 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Drugs for Vancomycin-Resistant Enterococcus Faecium Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Drugs for Vancomycin-Resistant Enterococcus Faecium Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Drugs for Vancomycin-Resistant Enterococcus Faecium Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Microbiotix
  2. 6.1.1 Microbiotix Company Information
  3. 6.1.2 Microbiotix Business Overview
  4. 6.1.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  6. 6.1.5 Microbiotix Recent Developments
  7. 6.2 MGB Biopharma Limited
  8. 6.2.1 MGB Biopharma Limited Company Information
  9. 6.2.2 MGB Biopharma Limited Business Overview
  10. 6.2.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  12. 6.2.5 MGB Biopharma Limited Recent Developments
  13. 6.3 Lytix Biopharma
  14. 6.3.1 Lytix Biopharma Company Information
  15. 6.3.2 Lytix Biopharma Business Overview
  16. 6.3.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  18. 6.3.5 Lytix Biopharma Recent Developments
  19. 6.4 LegoChem Biosciences
  20. 6.4.1 LegoChem Biosciences Company Information
  21. 6.4.2 LegoChem Biosciences Business Overview
  22. 6.4.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  24. 6.4.5 LegoChem Biosciences Recent Developments
  25. 6.5 Helix BioMedix
  26. 6.5.1 Helix BioMedix Company Information
  27. 6.5.2 Helix BioMedix Business Overview
  28. 6.5.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  30. 6.5.5 Helix BioMedix Recent Developments
  31. 6.6 Enanta Pharmaceuticals
  32. 6.6.1 Enanta Pharmaceuticals Company Information
  33. 6.6.2 Enanta Pharmaceuticals Business Overview
  34. 6.6.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  36. 6.6.5 Enanta Pharmaceuticals Recent Developments
  37. 6.7 Cellceutix Corporation
  38. 6.7.1 Cellceutix Corporation Company Information
  39. 6.7.2 Cellceutix Corporation Business Overview
  40. 6.7.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  42. 6.7.5 Cellceutix Corporation Recent Developments
  43. 6.8 Aphios Corporation
  44. 6.8.1 Aphios Corporation Company Information
  45. 6.8.2 Aphios Corporation Business Overview
  46. 6.8.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  48. 6.8.5 Aphios Corporation Recent Developments
  49. 6.9 Alvogen
  50. 6.9.1 Alvogen Company Information
  51. 6.9.2 Alvogen Business Overview
  52. 6.9.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  54. 6.9.5 Alvogen Recent Developments
  55. 6.10 Alchemia Limited
  56. 6.10.1 Alchemia Limited Company Information
  57. 6.10.2 Alchemia Limited Business Overview
  58. 6.10.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Product Portfolio
  60. 6.10.5 Alchemia Limited Recent Developments
7 North America
  1. 7.1 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026)
  3. 7.3 North America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026)
  3. 8.3 Europe Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026)
  3. 10.3 South America Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Drugs for Vancomycin-Resistant Enterococcus Faecium Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst